Lower liver cancer risk with antiviral therapy in chronic hepatitis B patients with normal to minimally elevated ALT and no cirrhosis-Reference-Cited by-同舟云学术

Lower liver cancer risk with antiviral therapy in chronic hepatitis B patients with normal to minimally elevated ALT and no cirrhosis

Published:2016-08 Issue:31 Volume:95 Page:e4433
ISSN:0025-7974
Container-title:Medicine
language:en
Short-container-title:

Author:

Hoang Joseph K.,Yang Hwai-I,Le An,Nguyen Nghia H.,Lin Derek,Vu Vinh D.,Chaung Kevin,Nguyen Vincent,Trinh Huy N.,Li Jiayi,Zhang Jian Q.,Chen Chien-Jen,Nguyen Mindie H.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Medicine

Reference31 articles.

1. Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures;Lavanchy;J Viral Hepat,2004

2. Viral hepatitis B;Lai;Lancet,2003

3. Hepatitis B virus. The major etiology of hepatocellular carcinoma;Beasley;Cancer,1988

4. Epidemiological characteristics and risk factors of hepatocellular carcinoma;Chen;J Gastroenterol Hepatol,1997

5. Hepatitis B e antigen and the risk of hepatocellular carcinoma;Yang;N Engl J Med,2002

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Decreased Hepatic Functional Reserve Increases the Risk of Piperacillin/Tazobactam-Induced Abnormal Liver Enzyme Levels: A Retrospective Case-Control Study;Annals of Pharmacotherapy;2024-06-05

2. Global elimination of HBV: Is it really achievable?;Journal of Viral Hepatitis;2024-05-26

3. Progress towards elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission update;The Lancet Gastroenterology & Hepatology;2024-04

4. Upper limit of normal ALT levels in health and metabolic diseases: Pooled analysis of 423,355 individuals with bootstrap modelling;Alimentary Pharmacology & Therapeutics;2024-02-19

5. Association of HBV Infection and Liver Enzymes with Risk of Adverse Liver Disease and All-Cause Death: A Marched Cohort Study in Eastern China;2024